Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

MS-L6

😃Good
Catalog No. T201371Cas No. 63498-32-8
Alias NSC34338, Agn-PC-0N3ahi

MS-L6 is an inhibitor of the mitochondrial respiratory complex I (ETC-I) with uncoupling properties. This product blocks oxidative phosphorylation (OXPHOS) by inhibiting NADH oxidation and exerting uncoupling effects. MS-L6 reduces mitochondrial membrane potential, inhibits ATP production, and induces mitochondrial dysfunction and apoptosis in tumor cells.

MS-L6

MS-L6

😃Good
Purity: 99.98%
Catalog No. T201371Alias NSC34338, Agn-PC-0N3ahiCas No. 63498-32-8
MS-L6 is an inhibitor of the mitochondrial respiratory complex I (ETC-I) with uncoupling properties. This product blocks oxidative phosphorylation (OXPHOS) by inhibiting NADH oxidation and exerting uncoupling effects. MS-L6 reduces mitochondrial membrane potential, inhibits ATP production, and induces mitochondrial dysfunction and apoptosis in tumor cells.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$41-In Stock
5 mg$78-In Stock
10 mg$124-In Stock
25 mg$249-In Stock
50 mg$398-In Stock
100 mg$630-In Stock
1 mL x 10 mM (in DMSO)$95-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.98%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
MS-L6 is an inhibitor of the mitochondrial respiratory complex I (ETC-I) with uncoupling properties. This product blocks oxidative phosphorylation (OXPHOS) by inhibiting NADH oxidation and exerting uncoupling effects. MS-L6 reduces mitochondrial membrane potential, inhibits ATP production, and induces mitochondrial dysfunction and apoptosis in tumor cells.
In vitro
In multiple cancer cell lines, MS-L6 dose-dependently reduces oxygen consumption rate (OCR) and ATP levels, triggering mitochondrial membrane potential loss and cytochrome c release to activate caspase-3 and induce apoptosis [1].
In vivo
In pharmacological studies using tumor xenograft mouse models, systemic administration of MS-L6 (at doses such as 10-20 mg/kg) leads to a significant reduction in tumor volume and weight; the treatment results in decreased intratumoral ATP concentrations and increased expression of apoptotic markers, demonstrating effective suppression of tumor progression through mitochondrial metabolic disruption [1].
SynonymsNSC34338, Agn-PC-0N3ahi
Chemical Properties
Molecular Weight548.4
FormulaC20H28Br2N4S2
Cas No.63498-32-8
SmilesN=C(NC1=CC=CC=C1)SCCCCCCSC(NC2=CC=CC=C2)=N.Br.Br
Storage & Solubility Information
StorageIn solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
H2O: 3.00 mg/mL (5.47 mM), Sonication is recommended.
DMSO: 100.00 mg/mL (182.35 mM), Sonication is recommended.
Solution Preparation Table
H2O/DMSO
1mg5mg10mg50mg
1 mM1.8235 mL9.1174 mL18.2349 mL91.1743 mL
5 mM0.3647 mL1.8235 mL3.6470 mL18.2349 mL
DMSO
1mg5mg10mg50mg
10 mM0.1823 mL0.9117 mL1.8235 mL9.1174 mL
20 mM0.0912 mL0.4559 mL0.9117 mL4.5587 mL
50 mM0.0365 mL0.1823 mL0.3647 mL1.8235 mL
100 mM0.0182 mL0.0912 mL0.1823 mL0.9117 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: buy MS-L6 | purchase MS-L6 | MS-L6 cost | order MS-L6 | MS-L6 chemical structure | MS-L6 in vivo | MS-L6 in vitro | MS-L6 formula | MS-L6 molecular weight